Teppei Shirakura's Colleagues at Glycomine
Teppei Shirakura's Contact Details
HQ
650-401-2016
650-401-2016
Location
Company
Glycomine
Glycomine
Teppei Shirakura's Company Details
Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist. The company's approach is to use replacement therapies – substrates, enzymes, or proteins – and to target those molecules to clinically relevant cellular compartments. Glycomine's lead drug candidate, GLM101, is a novel substrate replacement therapy in development to treat phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG), a rare disease representing a critical unmet medical need.
Frequently Asked Questions about Teppei Shirakura
Teppei Shirakura currently works for Glycomine Inc.
Teppei Shirakura's role at Glycomine Inc is director of chemistry.
Teppei Shirakura's email address is ***@glycomine.com. To view Teppei Shirakura's full email address, please signup to ConnectPlex.
Teppei Shirakura works in the Biotechnology industry.
Teppei Shirakura's colleagues at Glycomine are Steven Axon, Tristen Moors, Karen Morici, Helen Shapiro, Hicham Alaoui, Timothy Mills, Preeti Paliwal and others.
Teppei Shirakura's phone number is ["+15155093156"]